On June 11, Estun Cobot officially launched its second-generation humanoid robot, Codroid 02, at the 2025 Intelligent Robot Development Conference. It stands 170 cm tall, weighs 70 kg, has a single-arm payload of 5 kg, and has 31 degrees of freedom across its body (excluding dexterous hands), with all core components independently developed in-house.
Figure AI released an end-to-end reinforcement learning walking controller that lets the Figure 02 humanoid robot learn a human-like gait in simulation by imitating human reference trajectories through rewards, including heel strike, toe push-off, and arm swing. Training runs in parallel across thousands of robots in GPU-accelerated physics simulation, collecting years of simulated data in hours, and combines domain randomization with kHz-level torque feedback control to achieve zero-shot transfer to the real robot; 10 Figure 02 units run the same neural network without individual tuning.
Why it matters: The original text provides details on the training method and sim-to-real transfer for Figure 02's reinforcement-learning-based human-like walking, offering insight into its technical approach.
A Kessler Foundation case study shows that Wandercraft's self-balancing Atalante X exoskeleton helped a 64-year-old patient with chronic left-sided hemiplegia from stroke complete four weeks of robot-assisted walking training, with gait speed rising from 0.09 m/s to 0.19 m/s, cadence increasing 27.8%, and no adverse events. Its powered dynamic ankle joint can replicate physiological gait mechanics, improving weight-bearing symmetry and propulsion. The authors stress that more research is still needed to verify the results, which were presented at the American Physical Therapy Association annual conference.
Wandercraft publicly demonstrated its Personal Exoskeleton prototype for the first time at the 2024 Paralympic Torch Relay, with trained pilot Thibault Simon, who has quadriplegia, operating it to walk while carrying the torch. The exoskeleton is self-balancing, has 12 degrees of freedom and 12 motors, and lets users walk without assistive devices. The device is still in late-stage development, with clinical trials in the United States upcoming and commercialization targeted for the coming years.